FilingFirehose · free AI preview
ONCOLYTICS BIOTECH INC
ONCY · AI-generated SEC analysis preview · refreshes when data changes
⚠️ Red flag 8-Ks: 1
Types: Officer Departure
Oncolytics Biotech (ONCY) reported one officer departure via 8-K filing on June 2, 2026, with no detected cyber incidents in the past 90 days. While the near-term signal is limited, biotech companies face persistent dilution pressures and financing dependencies that warrant deeper analysis. The full $49 Report extends the timeline to 12 months of SEC filings, calculates dilution risk scores, contextualizes the officer departure against executive stability trends, and maps financing history alongside AI-detected risk signals. The full $49 Report adds quantified dilution trajectory, 8-K context, and 12-month financing patterns.
Want the full 5-section $49 Report on ONCY?
Dilution risk score · 12 months of 8-K context · financing history · AI risk signals · bottom-line framing. Delivered in ~5 minutes.
See a real sample report →
This preview was AI-generated from FilingFirehose's SEC EDGAR ingestion pipeline.
Not investment advice. Verify all claims against original filings.